Molecular and Precision Rehabilitation Molecular Mechanisms Linking Mitochondrial Dysfunction, Inflammation, and Muscle Degeneration with Functional Decline and Rehabilitation Response in Neuromuscular Disease

Abstract

Neuromuscular diseases frequently produce progressive weakness, fatigue, reduced mobility, and variable rehabilitation outcomes, yet the combined influence of mitochondrial dysfunction, inflammation, muscle degeneration, and functional decline on rehabilitation response remains insufficiently integrated within a single quantitative framework. This study aimed to examine these relationships and identify the strongest predictors of functional deterioration and rehabilitation responsiveness in individuals with neuromuscular disease. A quantitative, cross-sectional, case-study-based design was employed using a structured 30-item, five-point Likert-scale questionnaire administered to 240 participants representing neuromuscular clinical and rehabilitation cases, including muscular dystrophies, inflammatory myopathies, motor neuron diseases, peripheral neuropathies, and neuromuscular junction disorders. The principal variables were mitochondrial dysfunction, inflammation, muscle degeneration, functional decline, and rehabilitation response. Data were analyzed using descriptive statistics, Cronbach’s alpha, Pearson correlation, and multiple regression at p < .05. Within the manuscript’s illustrative analytical model, the instrument demonstrated excellent overall reliability, α = .93. Descriptive findings showed high mitochondrial dysfunction (M = 3.71, SD = 0.68), inflammation (M = 3.58, SD = 0.72), muscle degeneration (M = 3.76, SD = 0.65), and functional decline (M = 3.69, SD = 0.70), while rehabilitation response remained moderate (M = 2.94, SD = 0.74). Muscle degeneration was strongly correlated with functional decline (r = .72, p < .001), whereas functional decline was strongly and negatively associated with rehabilitation response (r = -.68, p < .001). Mitochondrial dysfunction, inflammation, and muscle degeneration jointly explained 61.0% of functional-decline variance, F (3,236) = 123.10, p < .001, with muscle degeneration as the strongest predictor (β = .49). The rehabilitation model explained 56.0% of variance, F (4,235) = 74.80, p < .001, with functional decline emerging as the strongest negative predictor (β = -.39). These findings support individualized precision-rehabilitation strategies incorporating biological burden, structural muscle deterioration, and functional status when planning treatment intensity, monitoring recovery, and anticipating rehabilitation outcomes. Importantly, the manuscript identifies these statistics as illustrative and requiring verification with final participant-level SPSS data before being presented as completed empirical evidence.